A5068776686- Chemotherapy-induced cardiotoxicity and mitigation
- Venous Thromboembolism Diagnosis and Management
- Childhood Cancer Survivors' Quality of Life
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiac Imaging and Diagnostics
- Viral Infections and Immunology Research
- Cancer Treatment and Pharmacology
- Cardiac tumors and thrombi
- Acute Lymphoblastic Leukemia research
- Central Venous Catheters and Hemodialysis
- Family Support in Illness
Kantonsspital Baden
2023-2024
University Hospital of Bern
2019-2020
University of Bern
2019-2020
University of Zurich
2018
Low-molecular-weight heparin has been the preferred treatment of cancer-associated thrombosis (CAT); however, emerging data support use direct oral anticoagulants (DOACs).The Memorial Sloan Kettering Cancer Center Clinical Pathway served as institutional guideline for rivaroxaban to treat CAT since 2014. Key elements are recommend against a DOAC in patients with active gastrointestinal (GI) or genitourinary tract lesions, and prespecified dose reduction elderly (75+ years old). We present...
Abstract Purpose Reported prevalence of cancer-related fatigue (CRF) among childhood cancer survivors (CCS) varies widely, and evidence on factors associated with CRF CCS is limited. We aimed to investigate the its adult in Switzerland. Methods In a prospective cohort study, we invited who survived at least 5 years since last diagnosis, were diagnosed when age 0–20 treated Inselspital Bern between 1976 2015 complete two fatigue-measuring instruments: Checklist Individual Strength subjective...
Background Cardiovascular disease is the leading nonmalignant cause of late deaths in childhood cancer survivors. and cardiac dysfunction can remain asymptomatic for many years, but eventually lead to progressive with high morbidity mortality. Early detection intervention are therefore crucial improve outcomes. Objective In our study, we aim assess prevalence preclinical adult survivors using conventional speckle tracking echocardiography; determine association between treatment-related risk...
Abstract Background The importance of clinical parameters for predicting short-term mortality in hemodynamically stable patients with pulmonary embolism (PE) is acknowledged within the Pulmonary Embolism Severity Index (PESI) Score. Little known about value novel biomarkers this context. Given pathophysiology PE, markers related to inflammation and thrombosis, such as interleukin 21 (IL-21), fractalkine plasminogen activator inhibitor 1 (PAI1) are particular interest. Purpose To identify new...
Abstract Introduction Cardiovascular disease is the leading nonmalignant cause of late deaths in childhood cancer survivors. and cardiac dysfunction can remain asymptomatic for many years, but eventually lead to progressive with high morbidity mortality. Early detection intervention are therefore crucial improve outcome. In our study, we aim 1) assess prevalence early adult survivors using conventional speckle tracking echocardiography, 2) determine association between treatment-related risk...
<sec> <title>BACKGROUND</title> Cardiovascular disease is the leading nonmalignant cause of late deaths in childhood cancer survivors. and cardiac dysfunction can remain asymptomatic for many years, but eventually lead to progressive with high morbidity mortality. Early detection intervention are therefore crucial improve outcomes. </sec> <title>OBJECTIVE</title> In our study, we aim assess prevalence preclinical adult survivors using conventional speckle tracking echocardiography; determine...